These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16803573)

  • 21. Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.
    Ladenvall C; Gils A; Jood K; Blomstrand C; Declerck PJ; Jern C
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):955-62. PubMed ID: 17272741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. +1040 C/T polymorphism in coding region of thrombin-activatable fibrinolysis inhibitor gene and the risk of idiopathic recurrent fetal loss.
    Pruner I; Djordjevic V; Miljic P; Kovac M; Antonijevic N; Rakicevic L; Radojkovic D
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):679-82. PubMed ID: 20729722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications].
    Vorob'eva NM; Panchenko EP; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Khasanova ZB; Postnov AIu; Kirienko AI
    Ter Arkh; 2011; 83(12):43-8. PubMed ID: 22416444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
    Dusse LM; Cooper AJ; Lwaleed BA
    Clin Chim Acta; 2007 Mar; 378(1-2):1-6. PubMed ID: 17184758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome.
    Martínez-Zamora MA; Creus M; Tassies D; Bové A; Reverter JC; Carmona F; Balasch J
    Fertil Steril; 2010 Nov; 94(6):2437-40. PubMed ID: 20378110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
    Boffa MB; Koschinsky ML
    Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.
    Tàssies D; Roqué M; Monteagudo J; Martorell T; Sionis A; Arzamendi D; Heras M; Reverter JC
    Thromb Res; 2009 Nov; 124(5):614-8. PubMed ID: 19699511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia.
    Verkleij CJ; Stuijver DJ; van Zaane B; Squizzato A; Brandjes DP; Büller HR; Meijers JC; Gerdes VE
    Thromb Haemost; 2013 Feb; 109(2):214-20. PubMed ID: 23197299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels in inflammatory bowel diseases.
    Saibeni S; Bottasso B; Spina L; Bajetta M; Danese S; Gasbarrini A; de Franchis R; Vecchi M
    Am J Gastroenterol; 2004 Oct; 99(10):1966-70. PubMed ID: 15447757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
    Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
    Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
    Chen CC; Lee KD; Gau JP; Yu YB; You JY; Lee SC; Hsu HC; Chau WK; Ho CH
    Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO; Lisman T; van den Berg HM; Nieuwenhuis HK; Meijers JC; Bouma BN
    Thromb Haemost; 2001 Oct; 86(4):1035-9. PubMed ID: 11686321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population.
    Santamaría A; Borrell M; Oliver A; Ortín R; Forner R; Coll I; Mateo J; Souto JC; Fontcuberta J
    Am J Hematol; 2004 Aug; 76(4):348-52. PubMed ID: 15282667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
    Colucci M; Pentimone A; Binetti BM; Cramarossa M; Piro D; Semeraro N
    Thromb Haemost; 2002 Aug; 88(2):282-7. PubMed ID: 12195701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin activatable fibrinolysis inhibitor: at the nexus of fibrinolysis and inflammation.
    Colucci M; Semeraro N
    Thromb Res; 2012 Mar; 129(3):314-9. PubMed ID: 22113149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.
    Mosnier LO; Bouma BN
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2445-53. PubMed ID: 16960106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of single nucleotide polymorphisms of the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI antigen levels in healthy children and pediatric oncology patients.
    Knoefler R; Ludwig K; Kostka H; Kuhlisch E; Siegert G; Suttorp M
    Semin Thromb Hemost; 2003 Dec; 29(6):575-83. PubMed ID: 14719174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma thrombin-activatable fibrinolysis inhibitor levels and its Thr325Ile polymorphism in breast cancer.
    Chengwei X; Xiaoli M; Yuan Z; Li P; Shengjiang W; Chao Y; Yunshan W
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):698-703. PubMed ID: 23624357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.
    Acosta-Tejeda M; Baptista-González H; Rosenfeld-Mann F; Trueba-Gómez R; García-Latorre E
    Thromb Res; 2011 Oct; 128(4):e39-42. PubMed ID: 21708401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.